GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ectin Research AB (XSAT:ECTIN B) » Definitions » EV-to-EBIT

Ectin Research AB (XSAT:ECTIN B) EV-to-EBIT : -0.25 (As of Jun. 17, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Ectin Research AB EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Ectin Research AB's Enterprise Value is kr4.14 Mil. Ectin Research AB's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was kr-16.89 Mil. Therefore, Ectin Research AB's EV-to-EBIT for today is -0.25.

The historical rank and industry rank for Ectin Research AB's EV-to-EBIT or its related term are showing as below:

XSAT:ECTIN B' s EV-to-EBIT Range Over the Past 10 Years
Min: -0.45   Med: 0   Max: 1.22
Current: -0.25

During the past 4 years, the highest EV-to-EBIT of Ectin Research AB was 1.22. The lowest was -0.45. And the median was 0.00.

XSAT:ECTIN B's EV-to-EBIT is ranked worse than
100% of 426 companies
in the Biotechnology industry
Industry Median: 9.29 vs XSAT:ECTIN B: -0.25

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Ectin Research AB's Enterprise Value for the quarter that ended in Mar. 2024 was kr5.04 Mil. Ectin Research AB's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was kr-16.89 Mil. Ectin Research AB's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was -335.02%.


Ectin Research AB EV-to-EBIT Historical Data

The historical data trend for Ectin Research AB's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ectin Research AB EV-to-EBIT Chart

Ectin Research AB Annual Data
Trend Aug19 Aug20 Dec22 Dec23
EV-to-EBIT
- - 0.16 0.07

Ectin Research AB Quarterly Data
Aug19 Aug20 Mar21 Sep21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.05 0.25 0.16 0.07 -0.30

Competitive Comparison of Ectin Research AB's EV-to-EBIT

For the Biotechnology subindustry, Ectin Research AB's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ectin Research AB's EV-to-EBIT Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ectin Research AB's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Ectin Research AB's EV-to-EBIT falls into.



Ectin Research AB EV-to-EBIT Calculation

Ectin Research AB's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=4.139/-16.885
=-0.25

Ectin Research AB's current Enterprise Value is kr4.14 Mil.
Ectin Research AB's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-16.89 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ectin Research AB  (XSAT:ECTIN B) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Ectin Research AB's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Mar. 2024 ) =EBIT / Enterprise Value (Q: Mar. 2024 )
=-16.885/5.0399338
=-335.02 %

Ectin Research AB's Enterprise Value for the quarter that ended in Mar. 2024 was kr5.04 Mil.
Ectin Research AB's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-16.89 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ectin Research AB EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Ectin Research AB's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Ectin Research AB (XSAT:ECTIN B) Business Description

Traded in Other Exchanges
N/A
Address
Pepparedsleden 1, Molndal, SWE, 431 83
Ectin Research AB is a pharmaceutical company developing a novel treatment that eliminates cancer tumors. Its drug candidate MFA-370 engages in the treatment of metastatic bladder cancer, and has also shown potential in other cancers such as breast, colorectal and prostate cancer cells.

Ectin Research AB (XSAT:ECTIN B) Headlines

No Headlines